Masimo Corp. Price Target Raised to $32.00 at Roth Capital (MASI)
Roth Capital increased their target price on shares of Masimo Corp. (NASDAQ:MASI) from $29.00 to $32.00 in a research note issued on Thursday, Analyst Ratings Network reports. The firm currently has a “buy” rating on the stock. Roth Capital’s price objective would suggest a potential upside of 24.90% from the company’s current price.
A number of other firms have also recently commented on MASI. Analysts at Feltl & Co. raised their price target on shares of Masimo Corp. from $22.00 to $26.00 in a research note to investors on Thursday. They now have a “hold” rating on the stock. They noted that the move was a valuation call. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Masimo Corp. in a research note to investors on Thursday. They now have a $30.00 price target on the stock. Finally, analysts at BMO Capital Markets reiterated a “market perform” rating on shares of Masimo Corp. in a research note to investors on Thursday. They now have a $24.00 price target on the stock, up previously from $22.00. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $28.00.
Shares of Masimo Corp. (NASDAQ:MASI) traded down 9.73% during mid-day trading on Thursday, hitting $25.62. 1,152,919 shares of the company’s stock traded hands. Masimo Corp. has a 52-week low of $19.03 and a 52-week high of $29.08. The stock has a 50-day moving average of $27.12 and a 200-day moving average of $23.79. The company has a market cap of $1.447 billion and a P/E ratio of 26.30.
Masimo Corp. (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.26 by $0.01. The company had revenue of $131.40 million for the quarter, compared to the consensus estimate of $132.47 million. During the same quarter last year, the company posted $0.26 earnings per share. Masimo Corp.’s revenue was up 10.3% compared to the same quarter last year. Analysts expect that Masimo Corp. will post $1.15 EPS for the current fiscal year.
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.